VIMIZIM
VIMIZIM
Approved
DIN Number
02427184
Drug Class
Human
Market Date
Aug 27, 2014
Company
HC
Biomarin International Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02427184
AIG Number0155870001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
A16AB12 ELOSULFASE ALFA
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ELOSULFASE ALFAActive
Strength: 1 MG / ML
Monograph: ELOSULFASE ALFA